Opus Genetics Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, Opus Genetics stock has a consensus rating of "Strong Buy" and an average price target of $13.94. The average 1-year stock price forecast is 250.25% higher than the current stock price, while the lowest is $8.00 (+101.01%) and the highest is $20 (+402.51%).

Price Target: $13.94 (+250.25%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$8.00	$13.94	$14	$20
Change	+101.01%	+250.25%	+251.76%	+402.51%

Analyst Ratings

The average analyst rating for Opus Genetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	15	16	16	15	15	14
Buy	3	3	3	3	3	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	18	19	19	18	18	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lisa Walter RBC Capital	RBC Capital	Buy Reiterates $9 → $11	Buy	Reiterates	$9 → $11	+176.38%	Nov 11, 2026
Matthew Caufield H.C. Wainwright	H.C. Wainwright	Buy Reiterates $8 → $14	Buy	Reiterates	$8 → $14	+251.76%	Nov 11, 2026
Thomas Shrader BTIG	BTIG	Buy Maintains $12	Buy	Maintains	$12	+201.51%	Nov 11, 2026
Debanjana Chatterjee JonesTrading	JonesTrading	Buy Maintains $17	Buy	Maintains	$17	+327.14%	Nov 5, 2026
Kostas Biliouris Oppenheimer	Oppenheimer	Buy Reiterates $20	Buy	Reiterates	$20	+402.51%	Oct 21, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

13.37M

from 14.20M

-5.79%

from 14.20M

Revenue Next Year

12.41M

from 13.37M

-7.24%

from 13.37M

EPS This Year

-1.28

from -0.80

EPS Next Year

-0.75

from -1.28

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	589.00K	39.85M	19.05M	10.99M	14.20M	13.37M
Revenue Growth	-	6,665.71%	-52.20%	-42.30%	29.15%	-5.79%
Operating Income	-22.71M	18.23M	-10.56M	-34.07M	-38.60M	-59.13M
Net Income	-56.69M	17.89M	-9.99M	-57.53M	-49.59M	-131.82M
EPS	-	-	-	-	-0.80	-1.28
Free Cash Flow	-	-	-	-	-35.25M	-59.60M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	24.5M
Avg	13.4M
Low	5.2M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	72.6%
Avg	-5.8%
Low	-63.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.16
Avg	-1.28
Low	-1.41

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-